HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Riccardo Puntoni Selected Research

Poisoning

3/2004Adverse haematological outcome and environmental lead poisoning.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Riccardo Puntoni Research Topics

Disease

14Neoplasms (Cancer)
06/2009 - 10/2002
13Lung Neoplasms (Lung Cancer)
12/2018 - 01/2002
13Malignant Mesothelioma
06/2009 - 02/2003
6Genetic Predisposition to Disease (Genetic Predisposition)
07/2008 - 10/2002
6Mesothelioma
09/2007 - 01/2003
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2005 - 01/2002
2Cardiovascular Diseases (Cardiovascular Disease)
01/2015 - 04/2009
2Disease Progression
01/2015 - 06/2009
2Lung Diseases (Lung Disease)
10/2010 - 02/2003
1Chronic Obstructive Pulmonary Disease (COPD)
01/2015
1Necrosis
01/2015
1Vascular Diseases (Vascular Disease)
04/2009
1Asbestosis
07/2008
1Breast Neoplasms (Breast Cancer)
08/2007
1Carcinogenesis
12/2004
1Infections
08/2004
1Poliomyelitis (Polio)
08/2004
1Urinary Bladder Neoplasms (Bladder Cancer)
06/2004
1Respiratory Tract Diseases (Respiratory Tract Disease)
04/2004
1Poisoning
03/2004
1Herpes Zoster
01/2003
1Small Cell Carcinoma
01/2002

Drug/Important Bio-Agent (IBA)

14AsbestosIBA
12/2018 - 10/2002
5DNA (Deoxyribonucleic Acid)IBA
09/2006 - 01/2002
4Biomarkers (Surrogate Marker)IBA
01/2015 - 03/2004
4CarcinogensIBA
09/2007 - 11/2003
3SmokeIBA
01/2015 - 09/2007
3Biological ProductsIBA
06/2009 - 11/2003
2DNA AdductsIBA
10/2010 - 12/2004
2Environmental CarcinogensIBA
09/2007 - 03/2004
2Cytochrome P-450 CYP1A1 (CYP1A1)IBA
09/2007 - 07/2006
2Tumor Viral Antigens (Large T Antigen)IBA
07/2005 - 01/2003
2Coal (Coals)IBA
03/2004 - 01/2003
2Poliovirus VaccinesIBA
10/2003 - 05/2003
1C-Reactive ProteinIBA
01/2015
1Interleukin-8 (Interleukin 8)IBA
01/2015
1Estrogen ReceptorsIBA
06/2009
1Estrogen Receptor alphaIBA
06/2009
1Estrogen Receptor betaIBA
06/2009
1Mineral Fibers (Mineral Fiber)IBA
03/2008
1MesothelinIBA
09/2007
1Proteins (Proteins, Gene)FDA Link
09/2007
1Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA
09/2007
1Glutathione Transferase (Glutathione S-Transferase)IBA
08/2007
1Superoxide DismutaseIBA
06/2007
1glutathione S-transferase M1IBA
06/2007
1Proto-Oncogene Proteins c-metIBA
01/2006
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2006
1((3Z)- N- (3- chlorophenyl)- 3- ((3,5- dimethyl- 4- ((4- methylpiperazin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- N- methyl- 2- oxo- 2,3- dihydro- 1H- indole- 5- sulfonamide)IBA
01/2006
1Platelet-Derived Growth FactorIBA
09/2005
1platelet-derived growth factor ABIBA
09/2005
1Codon (Codons)IBA
07/2005
1Indicators and Reagents (Reagents)IBA
07/2005
1VaccinesIBA
08/2004
1SootIBA
06/2004
1Petroleum (Crude Oil)IBA
04/2004
1AutoantibodiesIBA
02/2003
1ErbB-2 ReceptorIBA
01/2002

Therapy/Procedure

2Therapeutics
06/2009 - 11/2003
1Secondary Prevention
11/2008